• 1
    Adinoff AD, Hollister MD, Roger J. Steroid-induced fractures and bone loss In patients with asthma. N Engl J Med 1983; 309: 601607.
  • 2
    Cooper C, Coupland C, Mitchell M. Rheumatoid arthritis, corticosteroid therapy and hip fracture. Ann Rheum Dis 1995; 54: 4952.
  • 3
    Dykman TR, Gluck OS, Murphy WA, Hahn TJ, Hahn BH. Evaluation of factors associated with glucocorticoid-induced osteopenia in patients with rheumatic diseases. Arthritis Rheum 1985; 28: 361368.
  • 4
    Hooyman JR, Melton Jl IIII, Nelson AM, O'Fallon MW, Lawrence Riggs B. Fractures after rheumatoid arthritis. Arthritis Rheum 1984; 27: 13531361.
  • 5
    McDougall R, Sibley J, Haga M, Russell A. Outcome in patients with rheumatoid arthritis receiving prednisone compared to matched controls. J Rheumatol 1994; 21: 12071213.
  • 6
    Saag KG, Koehnke R, Caldwell JR, et al. Low dose long-term corticosteriod therapy in rheumatoid arthritis: An analysis of serious adverse events. Am J Med 1994; 96: 115123.
  • 7
    Kanis JA & Pitt FA. Epidemiology of osteoporosis. Bone 1992; 13: S7S15.
  • 8
    Eastell R, Reid DM, Compston J, et al. A UK consensus group on management of glucocorticoid induced osteoporosis: an update. J Intern Med 1998; 244: 271292.
  • 9
    Gefeller O. Definitions of attributable risk. Public Health Rev 1995; 23: 343355.
  • 10
    Lis Y & Mann RD. The Vamp Research Multi-purpose Database in the U. K. J Clin Epidemiol 1995; 48: 431443.DOI: 10.1016/0895-4356(94)00137-f
  • 11
    Hollowell J. General Practice Research Database (GPRD): Scope and Quality of Data. London: Office of Population Censuses and Statistics., 1994.
  • 12
    Hall G. Pharmacoepidemiology using a UK Database of Primary Care Records. Pharmacoepidemiol Drug Saf 1992; 1: 3337.
  • 13
    Mann RD, Hall G, Chukwujindu J. Research implications of computerised primary care. Post Marketing Surveillance 1992; 5: 259268.
  • 14
    Anonymous. The general practice research database. Information for Researchers. London: Office for National Statistics, 1996.
  • 15
    Walley T & Mantgani A. The UK General Practice Research Database. Lancet 1997; 350: 10971099.DOI: 10.1016/s0140-6736(97)04248-7
  • 16
    Jick H, Jick SS, Derby LE. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. Br Med J 1991; 302: 766768.
  • 17
    Jick H, Terris BZ, Derby LE, Jick SS. Further validation of information recorded on a general practitioner based computerised data resource in the United Kingdom. Pharmacoepidemiol Drug Saf 1992; 1: 347349.
  • 18
    Nazareth I, King M, Haines A, Rangel L, Myers S. Accuracy of diagnosis of psychosis on general practice computer system. Br Med J 1993; 307: 3234.
  • 19
    Van Staa TP & Abenhaim L. The quality of information recorded on a UK database of primary care records: a study of hospitalization due to hypoglycemia and other conditions. Pharmacoepidemiol Drug Saf 1994; 3: 1521.
  • 20
    Van Staa TP, Leufkens B, Abenhaim L, Zhang B, Cooper C. Use of oral corticosteroids and risk of fractures. J Bone Miner Res 2000; 15: 9931000.
  • 21
    British National Formulary Number 32. British Medical Association and the Royal Pharmaceutical Society of Great Britain. Wallingford, England. Pharmaceutical Press. 1996, September, 1996.
  • 22
    Van Staa TP, Cooper C, Abenhaim L, Begaud B, Zhang B, Leufkens B. Utilisation of oral corticosteroids in the United Kingdom. Q J Med 2000; 93: 105111.
  • 23
    Van Staa TP, Abenhaim L, Cooper C, Zhang B, Leufkens HGM. The use of a large pharmaco-epidemiological database to study exposure to oral corticosteroids and risk of fractures: validation of study population and results. Pharmacoepidemiol Drug Saf 2000; 9: 359366.
  • 24
    Nortridge ME. Annotation: public health methods – attributable risk as a link between causality and public health action. Am J Public Health 1995; 85: 12021204.
  • 25
    Kleinbaum DG, Kupper LL, Morgenstern H. Epidemiologic research. Principles and Quantitative Methods. New York. Van Norstrand Reinhold Company Inc. 1982.
  • 26
    Miettinen OS. Stratification by a multivariate confounder score. Am J Epidemiol 1976; 104: 609620.
  • 27
    Pike MC & Anderson J. Some insights into Miettinen's multivariate confounder score approach to case-control study analysis. J Epidemiol Community Health 1979; 33: 104106.
  • 28
    Strauss D. On Miettinen's multivariate confounder score. J Clin Epidemiol 1998; 51: 233236.DOI: 10.1016/s0895-4356(97)00283-7
  • 29
    Shane E. Osteoporosis associated with illness and medications. In Osteoporosiseds MarcusR, FeldmanD, KelseyJ.San Diego: Academic Press, 1996; pp 925946.
  • 30
    Grisso JA, Capezuti E, Schwartz A. Falls as risk factors for fractures. In Osteoporosiseds MarcusR, FeldmanD, KelseyJ. San Diego: Academic Press, 1996; pp 599611.
  • 31
    Reid IR. Gluco-corticoid-induced osteoporosis and other forms of secondary osteoporosis. In Osteoporosis: Diagnosis and Managemented MeunierPJ.London: Martin Dunitz, 1998: 233250.
  • 32
    Cummings SR, Nevitt MC, Browner WS, et al. Risk factors for hip fractures in white woman. N Engl J Med 1995; 332: 767773.
  • 33
    Ross PD, Davis JW, Epstein RS, Wasnich RD. Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med 1991; 114: 919923.
  • 34
    Adachi JD, Bensen WG, Brown J, et al. Intermittent etidronate therapy to prevent corticosteroid induced osteoporosis. N Engl J Med 1997; 337: 382387.
  • 35
    Saag KG, Emkey R, Schnitzer TJ, et al. Alendronate for the prevention and treatment of glucocorticoid induced osteoporosis. N Engl J Med 1998; 339: 292299.
  • 36
    Roux C, Oriente P, Laan R, et al. Randomized trial of effect of cyclical etidronate in the prevention of corticosteroid induced bone loss. J Clin Endocrinol Metab 1998; 83: 11281133.